We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · November 01, 2021

Care in Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy

JAMA Ophthalmology


Additional Info

JAMA Ophthalmology
Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy: A Post Hoc Analysis of a Randomized Clinical Trial
JAMA Ophthalmol 2021 Oct 21;[EPub Ahead of Print], MG Maguire, D Liu, SB Bressler, SM Friedman, M Melia, CR Stockdale, AR Glassman, JK Sun

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading